AMA ramps up pressure to limit sale of e-cigarettes

The American Medical Association sent a letter to the CEOs of five of the largest commerce companies in the U.S. urging them to take action against the sale of illicit e-cigarette products on their platforms.

AMA’s letter, penned by the association’s CEO and Executive Vice President James Madara, MD, was sent to the heads of Amazon, Microsoft, LinkedIn, Facebook and Instagram­­. These companies own platforms where street sales of e-cigarette and vaping products occurs, as well as the sale of items used to create counterfeit vaping products. The AMA has long been involved in the fight against tobacco and cigarettes.

The letter comes at a time when an epidemic of lung injuries attributed to e-cigarette use has cropped up across the U.S. According to the CDC, the number of injuries topped 1,000 last week, while 18 deaths have been reported in 15 states. The CDC is investigating the cause of the lung injuries alongside several states. A recent report from The Wall Street Journal found many illicit vaping products have found a home online where sales can take place.

However, the agency has yet to discover any specific products across all the patients, and the exact cause for the lung disease has yet to be determined. Some patients with confirmed cases of lung injuries linked to vaping admitted to using products with THC and others may have used products purchased off the street.

“The rapid growth of vaping-related lung illness is frightening in scope and unexplained in nature,” Madara wrote in the letter.

The AMA asked the five company leaders to step up to ensure vaping products are not being sold across their platforms as the number of lung injury cases continues to rise.

“We urge you, as leaders of large technology platforms, to ensure that existing policies that ban the sale or transfer of illicit items (such as vaping products that contain THC) are enforced,” the letter concluded. … “It is time for e-commerce companies to take action to ban the sale of materials fueling the counterfeit vaping crisis.”

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”